Cibus (CBUS) Expected to Announce Earnings on Thursday

Cibus (NASDAQ:CBUS - Get Free Report) will likely be announcing its earnings results before the market opens on Thursday, May 8th. Analysts expect the company to announce earnings of ($0.66) per share and revenue of $1.15 million for the quarter.

Cibus (NASDAQ:CBUS - Get Free Report) last issued its quarterly earnings results on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing analysts' consensus estimates of ($0.68) by ($0.19). The business had revenue of $1.21 million for the quarter, compared to the consensus estimate of $1.13 million. Cibus had a negative net margin of 10,724.78% and a negative return on equity of 28.17%. On average, analysts expect Cibus to post $-3 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Cibus Trading Up 5.1 %

Shares of CBUS traded up $0.11 during mid-day trading on Friday, reaching $2.25. The company's stock had a trading volume of 75,165 shares, compared to its average volume of 174,220. Cibus has a 52 week low of $1.40 and a 52 week high of $19.56. The stock has a market cap of $73.91 million, a PE ratio of -0.10 and a beta of 1.70. The company's fifty day moving average price is $1.95 and its two-hundred day moving average price is $2.88.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. HC Wainwright reissued a "buy" rating and issued a $25.00 price target on shares of Cibus in a research note on Friday, March 21st. Canaccord Genuity Group lowered their target price on Cibus from $20.00 to $18.00 and set a "buy" rating for the company in a research note on Wednesday, January 22nd.

Institutional Investors Weigh In On Cibus

A hedge fund recently raised its stake in Cibus stock. Bank of America Corp DE lifted its position in shares of Cibus, Inc. (NASDAQ:CBUS - Free Report) by 113.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,536 shares of the company's stock after purchasing an additional 18,885 shares during the period. Bank of America Corp DE owned 0.13% of Cibus worth $99,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 33.81% of the company's stock.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.